Biotalys NV 2025 AR2
The report highlights Biotalys' pivotal year in 2025, marked by securing U.S. EPA regulatory approval for EVOCA, its lead protein-based biofungicide. The company advanced its pipeline, notably with promising field trial results for BioFun-6, and entered a strategic manufacturing partnership with 21st.BIO. Biotalys also established a post-harvest collaboration with AgroFresh to expand its biological solutions. On sustainability, the company reported on its ESG strategy, achieved a high My Green Lab certification score, and outlined its climate action plan to reduce emissions.
Company: Biotalys NV
Sector: Professional & technical services
Country: Belgium
Year: 2025
Type: AR2
Pages: 246
Back to company
Biotalys NV
Annual Report
The report highlights Biotalys' pivotal year in 2025, marked by securing U.S. EPA regulatory approval for EVOCA, its lead protein-based biofungicide. The company advanced its pipeline, notably with promising field trial results for BioFun-6, and entered a strategic manufacturing partnership with 21st.BIO. Biotalys also established a post-harvest collaboration with AgroFresh to expand its biological solutions. On sustainability, the company reported on its ESG strategy, achieved a high My Green Lab certification score, and outlined its climate action plan to reduce emissions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Net Zero Target
Employees